COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019

01/03/2019 - 18:10

ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2019 at 19.10 EET Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 [...]

Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call

01/03/2019 - 18:00

TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results and hold its Full Year and Fourth Quarter 2018 Earnings [...]

Information on total number of voting rights and shares composing the share capital as at February 28th, 2019

01/03/2019 - 18:00

Paris, March 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]

Information relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2019

01/03/2019 - 18:00

Paris, le 1 er mars 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]

Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting

01/03/2019 - 17:44

Rapid and significant reduction in skin lesions, 66% (p<0.001) and 76% (p<0.001) mean reduction in EASI score in 4 and 7 weeks, respectively. Rapid and significant resolution of worst itch and pain, 57% (p<0. [...]

IMV Inc. annonce le prix de son placement public

01/03/2019 - 17:05

DARTMOUTH, Nouvelle-Écosse, 01 mars 2019 (GLOBE NEWSWIRE) -- IMV Inc. (« IMV » ou la « société ») (NASDAQ : IMV; TSX : IMV), société de recherche clinique en immuno‑oncologie, annonce aujourd’hui le prix de son [...]

Medtronic EVP & CFO Karen L. Parkhill to Speak at Barclays Global Healthcare Conference

01/03/2019 - 17:00

DUBLIN - March 1, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Barclays Global Healthcare Conference 2019 on Tuesday, March 12, 2019, in Miami, [...]

Advance Notice: Audited Financial Statements' Announcement for The Year Ended 31 December 2018

01/03/2019 - 16:17

EASTPHARMA LTD. London, 1 March 2019 - EastPharma (EAST LI) informs that it will be releasing its audited financial statements for the year ended 31 December 2018 and a review of its main subsidiary DEVA Holding's [...]

IMV Inc. Announces Pricing of Public Offering

01/03/2019 - 16:02

DARTHMOUTH, Nova Scotia, March 01, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (NASDAQ: IMV; TSX: IMV), a clinical-stage immuno-oncology corporation, announced today the pricing of its previously- [...]

Medtronic EVP & MITG President Bob White to Speak at Cowen Healthcare Conference

01/03/2019 - 16:00

DUBLIN - March 1, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 39 th Annual Cowen and Company Healthcare Conference on Monday, March 11, 2019, in [...]

ESPN’s Scott Van Pelt to Host 2nd Annual Change for Charley on March 9 in Chicago

01/03/2019 - 15:30

The Annual Fundraising Gala Benefits EB Research Partnership to Advance Treatments and Cures for “Butterfly Children” with the Life-Threatening Skin Disease Epidermolysis Bullosa CHICAGO, March 01, 2019 (GLOBE NEWSWIRE [...]

Ventura Cannabis and Wellness Posts Conference Call Transcript

01/03/2019 - 15:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, March 01, 2019 (GLOBE NEWSWIRE) -- Venture [...]

Seelos Therapeutics to Present at the 39th Annual Cowen Health Care Conference

01/03/2019 - 15:00

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that they will participate in the 39th Annual Cowen Health Care [...]

Generex Investor Conference Call Now Available Online

01/03/2019 - 15:00

MIRAMAR, FL, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the information for [...]

Trident Brands Signs U.S. Distribution Agreement for Their Brain Armor® Brand with Threshold® Enterprises, Ltd.

01/03/2019 - 15:00

Brookfield, WI, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announces a U.S. distribution agreement for their Brain Armor® brand with [...]

TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings

01/03/2019 - 15:00

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced approximately $85 million [...]

Radius Health to Participate in 2019 Credit Suisse Global Healthcare Conference

01/03/2019 - 15:00

WALTHAM, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Company management will be attending and participating in the 2019 Credit Suisse Global Healthcare Conference [...]

CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs

01/03/2019 - 14:45

LAS VEGAS, March 01, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil [...]

Establishment Labs to Present at the Cowen 39th Annual Health Care Conference

01/03/2019 - 14:30

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]